Ways to improve ocular bioavailability for topical applications;Moyens d'amelioration de la biodisponibilite pour la vole topique

Journal Francais d'Ophtalmologie

Volumn 23, Issue 5, 2000, Pages 505-509

  Sirbat, D ^a   Marchal Heussler, L ^b   Hoffman, M ^c   Maincent, P ^c  

^a Cabinet d'Ophtalmologie   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Cyclodextrins; Inserts; Nan ocapsules; Nanoparticles; Ocular bioavailability; Prodrugs; Viscosifiers

Indexed keywords

CYCLODEXTRIN; EYE DROPS; LIPOSOME; NANOPARTICLE; PRODRUG;

ARTICLE; DRUG BIOAVAILABILITY; DRUG FORMULATION; HUMAN; VISCOSITY; BIOAVAILABILITY; EYE; METABOLISM;

BIOLOGICAL AVAILABILITY; EYE; HUMANS; OPHTHALMIC SOLUTIONS; PRODRUGS;

EID: 0034044706     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sirbat D, Kohler C, George JL, Mayeux D, Grilliat JP. Évaluation des effets systémiques cardiovasculaires et bronchiques d'un collyre β-bloquant : intérêt des tests à l'isoprénaline et à la carbamylcholine. Incidences thérapeutiques. Ophtalmologie, 1988;2:213-8.
2. Rozier A, Mazuel C, Grove J, Plazonnet B. Functionnality testing of gellan gum. Int J Pharm, 1997;153:191-8.
3. Järvinen K, Jarvinen T, Thomson DO, Stella VJ. The effect of a modified β-cyclodextrine on the aqueous stability and ocular absorption of pilocarpine. Curr Eye res, 1994;13:897-905.
4. Usayapant A, Karara AH, Narurkar MM. The effect of a hydroxypropyl- β-cyclodextrine on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm Res, 1991;8:1495-9.
5. Jansen T, Xhonneux B, Mesens J, Borgers M. Beta-cyclodextrines as vehicles in eye-drop formulation: an evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxic Res, 1990;7:459-68.
6. Jarho P, Jarvinen K, Urtti A, Stella VJ, Jarvinen T. Modified β-cyclodextrin (SBE7-beta-Cyd) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. J Pharm Pharmacol, 1996;48:263-9.
7. Puisieux F. Les liposomes : in «Formes Pharmaceutiques Nouvelles. Buri P, Puisieux F, Doelker E, Benoît JP. Lavoisier Tec et Doc, Paris». 1985;476-531.
8. Alleman E, Gurny R, Doelker E. Drug-loaded nanoparticles: preparation methods and drug targeting issues. Eur J Pharm Biopharm, 1993;39:173-91.
9. Marchal-Heussler L, Sirbat D, Hoffman M, Maincent P. Nanocapsules de β-bloquants : un nouveau vecteur de médicaments en ophtalmologie. J Fr Ophtalmol, 1991;14:371-5.